Covered recipient · General Payments record
LINDA E HUNGERFORD
Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry
General Payments · PY2018–2022
$1,436.72
- Reported across 99 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2022 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $195.07 | 11 |
By paying entity
PY2022 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $41.35 | 2 |
| Amgen Inc. | $40.57 | 2 |
| ITI, Inc. | $37.06 | 2 |
| Amarin Pharma Inc. | $17.21 | 1 |
| Avanir Pharmaceuticals, Inc. | $16.61 | 1 |
| Janssen Pharmaceuticals, Inc | $14.56 | 1 |
| ABBVIE INC. | $14.21 | 1 |
| Merck Sharp & Dohme Corporation | $13.50 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2022 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $14.21 | 05/07/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892876733 | CMS |
| Amarin Pharma Inc. | $17.21 | 04/11/2022 | Food and Beverage | Undisputed | 01/23/2026 | 913903967 | CMS |
| Amgen Inc. | $24.98 | 03/11/2022 | Food and Beverage | Undisputed | 01/23/2026 | 939262911 | CMS |
| Amgen Inc. | $15.59 | 04/18/2022 | Food and Beverage | Undisputed | 01/23/2026 | 939867585 | CMS |
| Avanir Pharmaceuticals, Inc. | $16.61 | 01/25/2022 | Food and Beverage | Undisputed | 01/23/2026 | 935917567 | CMS |
| ITI, Inc. | $15.95 | 01/20/2022 | Food and Beverage | Undisputed | 01/23/2026 | 945683625 | CMS |
| ITI, Inc. | $21.11 | 04/22/2022 | Food and Beverage | Undisputed | 01/23/2026 | 945683627 | CMS |
| Janssen Pharmaceuticals, Inc | $14.56 | 03/22/2022 | Food and Beverage | Undisputed | 01/23/2026 | 886129113 | CMS |
| Merck Sharp & Dohme LLC | $13.50 | 04/07/2022 | Food and Beverage | Undisputed | 01/23/2026 | 944588233 | CMS |
| Otsuka America Pharmaceutical, Inc. | $19.76 | 01/31/2022 | Food and Beverage | Undisputed | 01/23/2026 | 929294657 | CMS |
| Otsuka America Pharmaceutical, Inc. | $21.59 | 04/04/2022 | Food and Beverage | Undisputed | 01/23/2026 | 929294659 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022
- Generated from
- OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.